Home » Topics » Conferences

Conferences
RSS

Melanotropic peptide effective in men with erectile dysfunction

April 15, 1997

Initial clinical results with vinpocetine for urge incontinence

April 15, 1997

Moxisylyte recommended as first-line therapy for erectile dysfunction

April 15, 1997

Transurethral alprostadil/prazosin for erectile dysfunction

April 15, 1997

Mechanism of impaired erection with finasteride elucidated

April 15, 1997

In vitro antitumor activity of lactoferrin

April 15, 1997

Fluoxetine for the management of premature ejaculation

April 15, 1997

Eisai prepares potent antitumor agents

April 11, 1997

TX-1877: new hypoxic cell radiation enhancer

April 11, 1997

Fujisawa describes new oral cephem antibiotic

April 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.